무증상 갑상선기능저하증의 진단과 치료: 2023 대한갑상선학회 진료 권고안
Diagnosis and Management of Subclinical Hypothyroidism: The 2023 Clinical Practice Guideline, Korean Thyroid Association
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Subclinical hypothyroidism (SCH) is characterized by elevated serum thyroid-stimulating hormone (TSH) levels and normal free thyroxine levels. The Korean Thyroid Association recently issued guidelines for managing SCH. Based on the Korea National Health and Nutrition Examination Survey (2013-2015), a serum TSH level of 6.8 mIU/L is the reference value for SCH. SCH is classified as mild (TSH 6.8-10.0 mIU/L) or severe (TSH > 10.0 mIU/L), and patients are categorized as adult (age < 70 years) or elderly (age ≥ 70 years). Levothyroxine treatment (LT4-Tx) is not recommended for mild or even severe SCH in elderly patients. Immediate LT4-Tx can be given to adults in most cases, but not to women who are pregnant, patients with progressive disease, or patients with underlying coronary artery disease, heart failure, or dyslipidemia.
Abstract
Subclinical hypothyroidism (SCH) is characterized by elevated serum thyroid-stimulating hormone (TSH) levels and normal free thyroxine levels. The Korean Thyroid Association recently issued guidelines for managing SCH. Based on the Korea National Health and Nutrition Examination Survey (2013-2015), a serum TSH level of 6.8 mIU/L is the reference value for SCH. SCH is classified as mild (TSH 6.8-10.0 mIU/L) or severe (TSH > 10.0 mIU/L), and patients are categorized as adult (age < 70 years) or elderly (age ≥ 70 years). Levothyroxine treatment (LT4-Tx) is not recommended for mild or even severe SCH in elderly patients. Immediate LT4-Tx can be given to adults in most cases, but not to women who are pregnant, patients with progressive disease, or patients with underlying coronary artery disease, heart failure, or dyslipidemia.
참고문헌 (22)
- Chung HK, "2023 Korean Thyroid Association management guidelines for patients with subclinical hypothyroidism", Int J Thyroidol, 16, pp.32~50 (2023)
- Kim WG, "Thyroid stimulating hormone reference range and prevalence of thyroid dysfunction in the Korean population : Korea National Health and Nutrition Examination Survey 2013 to 2015", Endocrinol Metab(Seoul), 32, pp.106~114 (2017)
- Park SY, "Age-and gender-specific reference intervals of TSH and free T4 in an iodine-replete area : data from Korean National Health and Nutrition Examination Survey IV(2013-2015)", PLoS One, 13, pp.e0190738~ (2018)
- Kim M, "Reference interval for thyrotropin in a ultrasonography screened Korean population", Korean J Intern Med, 30, pp.335~344 (2015)
- Choi HS, "Prevalence of subclinical hypothyroidism in two population based-cohort : Ansung and KLoSHA cohort in Korea", J Korean Thyroid Assoc, 3, pp.32~40 (2010)
- Jang YY, "Reference interval of serum thyroid hormones in healthy Korean adults", J Prev Med Public Health, 41, pp.128~134 (2008)
- Yoo WS, "Comparison of thyroid-stimulating hormone results from eight different reagents and assay-specific Korean reference interval for subclinical hypothyroidism treatment", Int J Thyroidol, 16, pp.166~174 (2023)
- Garber JR, "Clinical practice guidelines for hypothyroidism in adults : cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association", Thyroid, 22, pp.1200~1235 (2012)
- Peeters RP, "Subclinical hypothyroidism", N Engl J Med, 376, pp.2556~2565 (2017)
- Stott DJ, "Thyroid hormone therapy for older adults with subclinical hypothyroidism", N Engl J Med, 376, pp.2534~2544 (2017)
- Mooijaart SP, "Association between levothyroxine treatment and thyroid-related symptoms among adults aged 80 years and older with subclinical hypothyroidism", JAMA, 322, pp.1977~1986 (2019)
- Rodondi N, "Subclinical hypothyroidism and the risk of coronary heart disease and mortality", JAMA, 304, pp.1365~1374 (2010)
- Chaker L, "Subclinical hypothyroidism and the risk of stroke events and fatal stroke : an individual participant data analysis", J Clin Endocrinol Metab, 100, pp.2181~2191 (2015)
- Gencer B, "Subclinical thyroid dysfunction and the risk of heart failure events : an individual participant data analysis from 6 prospective cohorts", Circulation, 126, pp.1040~1049 (2012)
- Baumgartner C, "Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation", Circulation, 136, pp.2100~2116 (2017)
- Feller M, "Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism : a systematic review and meta-analysis", JAMA, 320, pp.1349~1359 (2018)
- Pearce SH, "2013 ETA guideline : management of subclinical hypothyroidism", Eur Thyroid J, 2, pp.215~228 (2013)
- Razvi S, "The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism : randomized, crossover trial", J Clin Endocrinol Metab, 92, pp.1715~1723 (2007)
- Yi KH, "2023 revised Korean Thyroid Association guidelines for the diagnosis and management of thyroid disease during pregnancy and postpartum", Int J Thyroidol, 16, pp.51~88 (2023)
- Mammen JS, "Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults : findings from the baltimore longitudinal study of aging", Thyroid, 25, pp.979~986 (2015)
- Abbey EJ, "Thyroid hormone supplementation and all-cause mortality in community-dwelling older adults : results from the Baltimore longitudinal study of aging", J Am Geriatr Soc, 69, pp.1283~1290 (2021)
- Gavigan C, "Levothyroxine dosing in older adults : recommendations derived from the Baltimore longitudinal study of aging", Endocr Pract, 29, pp.612~617 (2023)